This week we take a look at growing tensions within Oregon’s Psilocybin Advisory Board, which reached a crescendo yesterday with the resignation of the Board’s chairman. We’re planning on sharing a slightly longer piece on psychedelic-assisted therapy infrastructure next week: stay tuned. With policies expected to be finalised this Spring and licences to be issued in just under 10 months…


Previous articlePT300 – Dr. Richard C. Schwartz – Vital Psychedelic Conversations
Next articleNuminus Expands Natural Psychedelic Research with New Biosecurity License